APPNA Oklahoma Chapter

Unraveling the genetics, diagnostic markers, and therapeutic targets of premature coronary artery disease
❤️ Why Your Support Matters — Especially Now

Pakistan faces one of the highest cardiovascular burdens in the world. Premature coronary artery disease (PCAD) is alarmingly common, with over half of PCI patients presenting with early-onset disease. These young patients urgently need breakthroughs that only modern, high-resolution science can deliver.
Your support drives the discovery of genomic, proteomic, and lipidomic markers that can change diagnosis and treatment for future generations.
💰 Our Goal

Target: $50,000
Your contribution directly funds advanced sample processing, proteomic/lipidomic assays, and whole-genome sequencing — the tools essential for uncovering new diagnostic and therapeutic targets.

Investigating Diagnostic Biomarkers & Therapeutic Targets of Premature Coronary Artery Disease in PAKISTAN- Proteomics & Whole Genome Sequencing 🔬 Support the PCAD Research InitiativeUnraveling the genetics, diagnostic markers, and therapeutic targets of premature coronary artery disease❤️ Why Your Support Matters — Especially NowPakistan faces one of the highest cardiovascular burdens in the world. Premature coronary artery disease...

APPNA Oklahoma will organize a health fair this October. We are also pleased to share that the OSMA Foundation has approved a grant to support this important project.

A heartfelt thank you goes out to our dedicated volunteers, whose efforts make these initiatives both possible and successful.